HOLX Share Price

Open 42.28 Change Price %
High 42.55 1 Day 0.06 0.14
Low 42.12 1 Week -0.30 -0.70
Close 42.29 1 Month 1.47 3.60
Volume 1827630 1 Year 7.94 23.11
52 Week High 42.97
52 Week Low 32.64
HOLX Important Levels
Resistance 2 42.69
Resistance 1 42.52
Pivot 42.32
Support 1 42.06
Support 2 41.89
NASDAQ USA Most Active Stocks
MU 28.43 7.40%
MU 28.43 7.40%
MU 28.43 7.40%
FNFG 10.18 -0.20%
FTR 2.09 7.73%
FTR 2.09 7.73%
ASTI 0.00 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
PGRX 0.06 200.00%
AMCF 0.10 100.00%
VALV 0.04 100.00%
LOCM 0.09 50.00%
BGMD 0.08 33.33%
ESMC 0.12 33.33%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Hologic, Inc. (NASDAQ: HOLX)

HOLX Technical Analysis 5
As on 24th Mar 2017 HOLX Share Price closed @ 42.29 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 37.95 & Strong Buy for SHORT-TERM with Stoploss of 40.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
HOLX Target for March
1st Target up-side 42.48
2nd Target up-side 43.81
3rd Target up-side 45.14
1st Target down-side 38.68
2nd Target down-side 37.35
3rd Target down-side 36.02
HOLX Other Details
Segment EQ
Market Capital 5513593344.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.hologic.com
HOLX Address
HOLX
35 Crosby Drive
Bedford, MA 01730
United States
Phone: 781-999-7300
HOLX Latest News
Interactive Technical Analysis Chart Hologic, Inc. ( HOLX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Hologic, Inc.
HOLX Business Profile
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women. The Company operates in four segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Company sells and services its products through a combination of direct sales and service forces and a network of independent distributors and sales representatives. On August 1, 2012, the Company acquired Gen-Probe Incorporated (Gen-Probe). Gen-Probe is engaged in molecular diagnostics products and services, which are used to diagnose human diseases, screen donated human blood and test transplant compatibility. In March 2013, it announced that it has completed its sale of the LIFECODES business unit to Immucor, Inc.